.png){kind=logo}
Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Pharmaceutics Pharmacist Competitive Exams
Q. Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Ans → enteric coating
Explanation →
This question is taken from the test/quiz post: one liners Pharmaceutics| B.Pharmacy| Pharmacy file-4 - attemp/practice
More oneliners in - one liners Pharmaceutics| B.Pharmacy| Pharmacy file-4
Q. The process of separating the lighter particles of a powder from the heavier ones by means of an up- ward-directed stream of fluid (gas or liquid).
Ans → elutriation
Explanation →
Q. Technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures,
Ans → embedding
Explanation →
Q. Process of enclosing a drug in a (micro or nano) particle (capsule, liposome, polymer).
Ans → encapsulation
Explanation →
Q. Non-fluid colloidal network or polymer network that is expanded throughout its whole volume by a fluid.
Ans → gel
Explanation →
Q. Solutions (aqueous or oily), emulsions, or suspensions for rectal administration of medicaments for cleansing, diagnostic, or therapeutic purposes.
Ans → enemas
Explanation →
Q. Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Ans → enteric coating
Explanation →
Q. Use of products containing genetic material (e.g., pDNA, antisense DNA, si RNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological properties of living cells.
Ans → gene therapy
Explanation →
Q. Summary of operations carried out to convert a pharmacologically active compound into a dosage form suitable for administration.
Ans → formulation
Explanation →
Q. Powder particles, which have been aggregated to form larger irregular particles, usually of 0.5–2 mm diameter.
Ans → granules
Explanation →
Q. The Process of contact and adhesion whereby particles in dispersion form larger-size clusters.
Ans → flocculation
Explanation →
Q. Process in which powder particles are made to aggregate to larger particles called granules.
Ans → granulation
Explanation →
Q. An aqueous solution used for the prevention and treatment of mouth and throat infections.
Ans → gargle
Explanation →
Q. Pace at which a drug along with the stomach content leaves and enters the duodenum.
Ans → gastric emptying rate
Explanation →
Q. Time required for the concentration of a reactant in a given reaction to reach a value that is the arith- metic mean of its initial and final (equilibrium) values.
Ans → half life
Explanation →
Q. Crystalline form of a compound in which water molecules are part of the crystal structure.
Ans → hydrate
Explanation →
More one-liners in - Pharmaceutics
Q. A molecule that seeks out electrons, also known as a Lewis Acid or an electron pair acceptor.
Ans → Electrophile
Explanation →
Q. Name the structure embedded in the dermis from which hair grows
Ans → hair follicle
Explanation →
Q. Name the cell envelope structure outside the cell wall in some bacteria that allows bacteria to adhere to surfaces,
Ans → glycocalyx
Explanation →
Q. Memberane-body antibody monomer functioning as receptor on the surface of B cells
Ans → IgD
Explanation →
Q. Carbohydrates are the polyhydroxyaldehydes or ketones, or compounds which produce them on
Ans → Hydrolysis
Explanation →
Q. The lipids that possess both hydrophobic (non -polar) and hydrophilic (polar) groups are known as
Ans → amphipathic
Explanation →
Q. Which are the essential fatty acids that need to be supplied in the diet.
Ans → PUFA
Explanation →
Q. For a substance, the time required for the amount of a drug or a substance in a biological system to be reduced to one-half of its value by biological processes when the rate of removal is approximately exponential.
Ans → biological half life
Explanation →
Q. The mechanism by which regulatory T cells inhibit self-reactive immune responses in T cells that have already exited the thymus
Ans → peripheral tolerance
Explanation →
Q. Process of agglomeration that converts fine powders or granules of bulk drugs and excipients into small, free-flowing, spherical, or semi-spherical units, referred to as pellets.
Ans → pelletization
Explanation →
Q. A a term applied to an atom or molecule having one or more free valencies.
Ans → radical
Explanation →
Q. Process of enclosing a drug in a (micro or nano) particle (capsule, liposome, polymer).
Ans → encapsulation
Explanation →
Q. A negative sign of free energy indicates that the reaction is
Ans → Exergonic or spontaneous
Explanation →
Q. Which is the simplest form of glycolipids which occur in the membranes of nervous tissue.
Ans → Cerebrosides
Explanation →
Q. The representation of a compound by two or more canonical structures in which the valence electrons are rearranged to give structures of similar probability.
Ans → resonance
Explanation →
Q. A Substance that absorbs sufficient moisture from the atmosphere to dissolve itself.
Ans → deliquescent
Explanation →
Q. Name the term that refers to a polar molecule or portion of a molecule capable of strong attraction to water molecules
Ans → hydrophilic
Explanation →
Q. A common STI of the reproductive system caused by Neisseria gonorrhoeae
Ans → Gonorrheao
Explanation →
Q. Emulsions in which the dispersed droplets are in the micron-size range.
Ans → microemulsions
Explanation →
Q. Organic substances occurring naturally, which are basic, forming salts with acids. The basic group is usually an amino function.
Ans → alkaloid
Explanation →
Q. An equimolar mixture of the two enantiomeric isomers of a compound.
Ans → racemic mixture
Explanation →
Q. The science and study of the ways in which the pharmaceutical formulation of administered agents can influence their pharmacodynamic and pharmacokinetic behaviour.
Ans → Biopharmaceutics
Explanation →
Q. Under physiological condition, the DNA structure is predominantly in the form
Ans → β-Form
Explanation →
Q. The scientist who observed that there exists a relationship between the contents of purines and pyrimidines in DNA structure
Ans → Erwin Chargaff
Explanation →
Q. The third stage of acute disease, during which the number of pathogens present in the host is greatest and the signs and symptoms of disease are most severe
Ans → period of illness
Explanation →
Q. Powder formulation in which individual doses of a powdered dosage form are separately wrapped
Ans → divided powder
Explanation →
Q. Antibody that is a monomer when functioning as a receptor on surface of B cells but a pentamer when secreted in response to specific pathogens;
Ans → IgM
Explanation →
Q. Technique that uses living organisms to make or modify products, to improve plants or animals, or to develop microorganisms for specific uses
Ans → biotechnology
Explanation →
Q. Name the highly branched storage polysaccharide that is found animal cells and bacteria
Ans → glycogen
Explanation →
Q. The amount of change in measured output per unit change in input.
Ans → Amplification
Explanation →
Q. Electronegativity is a measure of the attraction an atom has for electrons.
Ans → Electronegativity
Explanation →
Q. Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.
Ans → polymorphic transition
Explanation →